Harnessing CAR-Macrophages to Overcome Solid Tumour Barriers In Vivo
11:30 am - Tuesday 9th February 2027
- Exploring CAR-Macrophages as an alternative cell platform to overcome the limitations of CAR-T therapies in solid tumours
- Leveraging innate immune functions to penetrate the tumour microenvironment, enhance tumour infiltration, and drive durable responses
- Demonstrating the preclinical potential of in vivo cell therapy approaches to enhance accessibility for solid tumours
